Cargando…
Buying time: Drug repurposing to treat the host in COVID‐19H
In 2016 Fedson stated …. “For almost two decades, leading scientists and health officials have warned that we must prepare for a potentially devastating global pandemic of an infectious disease. Initial concern was focused on …H5N1…. More recently…a devastating outbreak of Ebola virus..(and) several...
Autores principales: | Martin, Jennifer H., Clark, Julian, Head, Richard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7311221/ https://www.ncbi.nlm.nih.gov/pubmed/32578336 http://dx.doi.org/10.1002/prp2.620 |
Ejemplares similares
-
Plitidepsin: a Repurposed Drug for the Treatment of COVID-19
por: Martinez, Miguel Angel
Publicado: (2021) -
Repurposed drugs for COVID-19: threshold and proof requirements for trials
por: Paul, Mical, et al.
Publicado: (2021) -
DRUG REPURPOSING—Overcoming the translational hurdles to clinical use
por: Martin, Jennifer H., et al.
Publicado: (2019) -
Is metformin ahead in the race as a repurposed host-directed therapy for patients with diabetes and COVID-19?
por: Singh, Awadhesh Kumar, et al.
Publicado: (2020) -
Repurposing biomedical informaticians for COVID-19
por: Sosa, Daniel N., et al.
Publicado: (2021)